StockClub

VTGN

VTGNVistaGen Therapeutics, Inc.$ --
VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.

VTGN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q3
Revenue
0M USD
YoY +29.5%
Operating Income
-20M USD
YoY -29.3%
Net Income
-19M USD
YoY -34.1%
EPS
-0.45$
YoY +2.2%

Revenue

$805,000
FY2024 Q4$1.1M
$1.1M
Q4
FY2025 Q1$84,000
$84,000
Q1
FY2025 Q2$267,000
$267,000
Q2
FY2025 Q3$501,000
$501,000
Q3
FY2025 Q4$486,000
$486,000
Q4
FY2026 Q1$244,000
$244,000
Q1
FY2026 Q2$502,000
$502,000
Q2
FY2026 Q3$805,000
$805,000
Q3
Actual
+$304,000 (+60.7%)

Net Income

$-53.4M
FY2024 Q4$-29.4M
$-29.4M
Q4
FY2025 Q1$-10.7M
$-10.7M
Q1
FY2025 Q2$-23.7M
$-23.7M
Q2
FY2025 Q3$-37.8M
$-37.8M
Q3
FY2025 Q4$-51.4M
$-51.4M
Q4
FY2026 Q1$-15.1M
$-15.1M
Q1
FY2026 Q2$-34.5M
$-34.5M
Q2
FY2026 Q3$-53.4M
$-53.4M
Q3
Actual
$-15.6M (-41.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021BEAT
Actual:$1.1M
Est:$877,300
FY2021BEAT
$1.1M
FY2022MISS
Actual:$1.1M
Est:$1.3M
FY2022MISS
$1.1M
FY2023BEAT
Actual:$-227,000
Est:$-403,000
FY2023BEAT
$-227,000
FY2024MISS
Actual:$1.1M
Est:$1.1M
FY2024MISS
$1.1M
FY2025MISS
Actual:$486,000
Est:$709,833
FY2025MISS
$486,000

Analyst Estimates